Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-remifentanil versus isoflurane for bleeding control in lumbar disc surgery
IRCT20250201064593N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of propofol, remifentanil and isoflurane in Lumbar disc disorder (LDD) (2 arms), sponsored by Alborz University of Medical Sciences. Primary endpoints: Intraoperative bleeding and Hemoglobin change. Started Apr 2025; status: completed.
02
Drugs
propofolremifentanilisoflurane
03
Conditions
Lumbar disc disorder (LDD)
Beyond the preview
Go deeper on IRCT20250201064593N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250201064593N1.